Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease

Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease

Abstract Background Deregulated autophagy in diabetes has been a field of many experimental studies recently. Impaired autophagy in diabetic kidneys orchestrates every step of diabetic nephropathy (DN) pathogenesis. This study aimed to evaluate three autophagy regulators; RUBCN, mTOR, and SESN2 as c...

Full description

Bibliographic Details
Main Authors:	Mona M. Watany, Hemat E. El-Horany, Marwa M. Elhosary, Ahmed A. Elhadidy
Format:	Article
Language:	English
Published:	BMC 2022-12-01
Series:	Molecular Medicine
Subjects:	Diabetic nephropathy Autophagy Mammalian/mechanistic target of rapamycin (mTOR) Rubicon (RUBCN) Sestrin-2 (SESN2) Insulin resistance, glycemic control
Online Access:	https://doi.org/10.1186/s10020-022-00580-8

Similar Items

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
by: Sandra Espinoza, et al.
Published: (2022-06-01)

Ancient founder mutation in RUBCN: a second unrelated family confirms Salih ataxia (SCAR15)
by: Mohammed Z. Seidahmed, et al.
Published: (2020-05-01)

Amino Acid Signaling for TOR in Eukaryotes: Sensors, Transducers, and a Sustainable Agricultural fuTORe
by: Nanticha Lutt, et al.
Published: (2022-03-01)

Potential Roles of Sestrin2 in Alzheimer’s Disease: Antioxidation, Autophagy Promotion, and Beyond
by: Shang-Der Chen, et al.
Published: (2021-09-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2021-02-01)

Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot Study
by: Victor N. Rivas, et al.
Published: (2023-10-01)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
by: Daniel J. Beard, et al.
Published: (2021-09-01)

Sestrin2 as a Potential Target for Regulating Metabolic-Related Diseases
by: Linan Gong, et al.
Published: (2021-11-01)

Metformin induces degradation of mTOR protein in breast cancer cells
by: Mohamed Alalem, et al.
Published: (2016-11-01)

Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction during High-Fat Diet-Induced Obesity
by: Meredith Krause-Hauch, et al.
Published: (2022-08-01)

Dengue activates mTORC2 signaling to counteract apoptosis and maximize viral replication
by: Christoph C. Carter, et al.
Published: (2022-09-01)

Comparing In-Vitro Effects of Two Immunosuppressive Drugs on the Expression of Foxp3 from Naïve CD4+ T Cells
by: Serineh Shajanian, et al.
Published: (2015-06-01)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01)

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
by: Jinjing Yang, et al.
Published: (2018-09-01)

FTO-mediated autophagy inhibition promotes non-small cell lung cancer progression by reducing the stability of SESN2 mRNA
by: Kai Wang, et al.
Published: (2024-03-01)

<i>SESN2</i> Could Be a Potential Marker for Diagnosis and Prognosis in Glioma
by: Lingdan Xu, et al.
Published: (2023-03-01)

Inositol-6 phosphate inhibits the mTOR pathway and induces autophagy-mediated death in HT-29 colon cancer cells
by: Ashok Kumar Pandurangan, et al.
Published: (2018-07-01)

Autophagy Stimulus-Dependent Role of the Small GTPase Ras2 in Peroxisome Degradation
by: Fahd Boutouja, et al.
Published: (2020-11-01)

Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies
by: Xiaoxue Bai, et al.
Published: (2023-05-01)

mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol
by: Joshua Blair, et al.
Published: (2018-06-01)

Direct physical interaction of active Ras with mSIN1 regulates mTORC2 signaling
by: Mehraj-U-Din Lone, et al.
Published: (2019-12-01)

Huge soft tissue PEComa with aggressive lung and bone metastases
by: Shih-Hao Tang, et al.
Published: (2017-09-01)

Rapamycin Rescues the Poor Developmental Capacity of Aged Porcine Oocytes
by: Seung Eun Lee, et al.
Published: (2014-05-01)

Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism
by: Yi-Bing Hu, et al.
Published: (2018-12-01)

Sestrin2 protects against hypoxic nerve injury by regulating mitophagy through SESN2/AMPK pathway
by: Cunyao Pan, et al.
Published: (2023-09-01)

Corrigendum: Sestrin2 protects against hypoxic nerve injury by regulating mitophagy through SESN2/AMPK pathway
by: Cunyao Pan, et al.
Published: (2024-04-01)

Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas
by: Elise F. Nassif, et al.
Published: (2023-02-01)

The Importance of the mTOR Regulatory Network in Chondrocyte Biology and Osteoarthritis
by: Elena V. Tchetina
Published: (2014-07-01)

Tyrosine Is a Booster of Leucine-Induced Muscle Anabolic Response
by: Kotaro Tamura, et al.
Published: (2023-12-01)

Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer
by: Mio Harachi, et al.
Published: (2021-04-01)

Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro
by: Eva Juengel, et al.
Published: (2019-06-01)

The mTOR inhibitor rapamycin suppresses trigeminal neuropathic pain and p-MKK4/p-p38 mitogen-activated protein kinase-mediated microglial activation in the trigeminal nucleus caudalis of mice with infraorbital nerve injury
by: Ji-Hee Yeo, et al.
Published: (2023-04-01)

Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway
by: Sooyeon Choi, et al.
Published: (2023-09-01)

mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer
by: Obaid Afzal, et al.
Published: (2022-10-01)

RETRACTED ARTICLE: Butein inhibits metastatic behavior in mouse melanoma cells through VEGF expression and translation-dependent signaling pathway regulation
by: Yu-Wei Lai, et al.
Published: (2015-12-01)

Signaling Pathways That Regulate the Crustacean Molting Gland
by: Donald L. Mykles, et al.
Published: (2021-06-01)

Tuberous Sclerosis Complex as Disease Model for Investigating mTOR-Related Gliopathy During Epileptogenesis
by: Till S. Zimmer, et al.
Published: (2020-09-01)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

SESN2 Knockdown Increases Betulinic Acid-Induced Radiosensitivity of Hypoxic Breast Cancer Cells
by: Antje Güttler, et al.
Published: (2022-12-01)